Snap-8 10mg

Snap-8 (Acetyl Octapeptide-3) is a synthetic eight-amino-acid peptide modeled on the N-terminal sequence of the SNAP-25 protein. It is classified as a cosmetic-research peptide and is structurally extended from the earlier hexapeptide Argireline, with two additional residues that influence binding interactions in laboratory models. Snap-8 is studied as a topical-research compound in the context of skin-surface science, often alongside GHK-Cu epidermal research peptides.

At the molecular level, Snap-8 is investigated for its ability to compete with native SNAP-25 within the SNARE complex, the protein assembly responsible for vesicle docking and acetylcholine release at neuromuscular junctions. In research skin models, this competitive interaction is examined as a way to attenuate the formation of fully functional SNARE complexes, thereby influencing contraction-related signaling in cultured cell systems. The peptide is non-toxic in standard cosmetic-research assays and is positioned as an alternative-pathway compound to botulinum-toxin (BoNT/A) research models.

Snap-8 is actively studied in cosmetic-research and topical-delivery contexts, particularly in formulations designed for expression-line research, surface-texture investigation, and skin-barrier modeling. Studies on the parent hexapeptide demonstrated significant influence on expression-line measurements in controlled laboratory protocols, supporting interest in the extended Snap-8 sequence as a related research tool (Blanes-Mira et al., 2002, International Journal of Cosmetic Science). Research groups continue to evaluate Snap-8 in stability, penetration, and formulation-compatibility studies relevant to topical research models, and it is often referenced alongside the Glow blend epidermal research formulation and KPV cosmetic-adjacent inflammation research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The development of Snap-8 emerged from a broader research direction in the early 2000s that sought peptide-based alternatives to neurotoxin-based research models for studying expression-line biology. Researchers at the Universidad Miguel Hernández identified a short hexapeptide segment (Argireline) derived from the N-terminus of SNAP-25 that was capable of mimicking the binding interface of this protein within the SNARE complex. Snap-8 was developed as an extended octapeptide built on the same conceptual framework.

Further work in cosmetic-science laboratories characterized the binding affinity, stability, and topical-formulation behavior of Snap-8. By extending the sequence to eight residues, formulators sought to improve interaction with the SNARE complex while retaining the favorable safety profile observed for the shorter parent peptide. Comparative studies have explored differences in binding kinetics, hydrolytic stability, and surface-penetration behavior between Argireline and Snap-8 in cell-free and skin-model systems.

Today, Snap-8 occupies a defined position within the cosmetic-research peptide category. It is referenced in topical-delivery research, formulation-compatibility studies, and SNARE-pathway investigations, and continues to be evaluated as a research tool for laboratories investigating peptide-based alternatives to neurotoxin research models.

1. SNARE-Complex Competitive Interaction

Snap-8 is studied for its capacity to compete with endogenous SNAP-25 in the assembly of the SNARE complex. In research models, this competitive interaction is examined as a mechanism that attenuates the efficiency of vesicle-fusion machinery, which in turn modulates signaling outputs associated with muscle contraction at the cellular level.

2. Acetylcholine-Release Signaling in Cellular Models

By influencing SNARE-complex formation, Snap-8 is investigated for its downstream effects on acetylcholine release in laboratory neuromuscular-junction models. Reduced vesicle-fusion efficiency in these in vitro systems is associated with diminished contraction-related signaling, providing a research framework distinct from neurotoxin-based experimental approaches.

3. Topical-Penetration and Surface-Layer Behavior

Snap-8 is characterized in formulation-research contexts for its behavior in topical carrier systems. Investigations examine its stability in cosmetic emulsions, compatibility with common excipients, and surface-layer penetration in skin-model assays such as Franz-cell diffusion studies. These properties make it a useful reference compound in topical-peptide research.

4. Expression-Line and Skin-Surface Research

In cosmetic-research models, Snap-8 is studied for its potential influence on visible expression-line metrics in controlled laboratory protocols. Research instruments measure micro-relief, surface texture, and contraction-related skin parameters in standardized cohorts, providing a quantitative readout of peptide activity in surface-research contexts.

Research Applications

Conclusion

Snap-8 is a synthetic octapeptide of considerable interest in cosmetic and topical-peptide research. Its position as a SNAP-25-derived sequence allows researchers to study SNARE-complex biology and contraction-related signaling in controlled laboratory settings. Continued investigation supports its role as a reference tool in topical-peptide and surface-research model studies.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.